Resources from the same session
Is there still a Cancer of Unknown Primary (CUP) in 2018? Who will mostly guide your decision: Your genetician, pathologist, radiologist, or your “gut feeling”?
Presenter: Gabor Lakatos
Session: Practicing oncologists and rare tumours
Resources:
Slides
Clinical case presentation
Presenter: Gabor Lakatos
Session: Practicing oncologists and rare tumours
Resources:
Slides
Webcast
Do clinical and “standard” pathological decision parameters dominate the treatment algorithms, or do we rely on the genetic signature?
Presenter: George Pentheroudakis
Session: Practicing oncologists and rare tumours
Resources:
Slides
Clinical case presentation
Presenter: Michalis Karamouzis
Session: Practicing oncologists and rare tumours
Resources:
Slides
Webcast
Rare tumours with recent treatment progresses
Presenter: Stefan Rauh
Session: Practicing oncologists and rare tumours
Resources:
Slides
Webcast
New treatment options in NET (incl combined radio nuclides
Presenter: Stefan Rauh
Session: Practicing oncologists and rare tumours
Resources:
Slides
Webcast
Should nuclear medicine be a mandatory treatment option for NET’s in 2018?
Presenter: Ambros Beer
Session: Practicing oncologists and rare tumours
Resources:
Slides
Webcast
Closing remarks: The role of the PO in rare tumor management / Management issues of rare cancer from a community oncology point of view
Presenter: Stefan Rauh
Session: Practicing oncologists and rare tumours
Resources:
Slides
Webcast